Paradigm Biocapital Advisors LP Compass Pathways PLC Transaction History
Paradigm Biocapital Advisors LP
- $2.47 Billion
- Q2 2024
A detailed history of Paradigm Biocapital Advisors LP transactions in Compass Pathways PLC stock. As of the latest transaction made, Paradigm Biocapital Advisors LP holds 2,335,926 shares of CMPS stock, worth $19.9 Million. This represents 0.81% of its overall portfolio holdings.
Number of Shares
2,335,926
Previous 2,390,988
2.3%
Holding current value
$19.9 Million
Previous $20.4 Million
2.31%
% of portfolio
0.81%
Previous 0.77%
Shares
4 transactions
Others Institutions Holding CMPS
# of Institutions
144Shares Held
29.2MCall Options Held
156KPut Options Held
563K-
Tcg Crossover Management, LLC Palo Alto, CA3.86MShares$32.9 Million4.93% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.67MShares$31.3 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.38MShares$28.9 Million0.01% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.01MShares$17.1 Million0.16% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.61MShares$13.7 Million2.03% of portfolio
About COMPASS Pathways plc
- Ticker CMPS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 42,522,400
- Market Cap $363M
- Description
- COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...